Table 2 Cox regression analysis on mortality, 2-level definition of corticosteroid treatment, including CCI (non-rheumatologic comorbidities vs rheumatologic comorbidities only)

From: Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases

	HR (95% CI)	Adj HR (95% IC)
No GC	Ref	Ref
GC	0.99 (0.57, 1.72)	1.35 (0.74, 2.47)
Female gender		0.65 (0.36, 1.18)
Age	-	*1.11 (1.07, 1.15)*
HAQ	-	1.36 (0.90, 2.05)
CCI >1	-	*2.29 (1.23, 4.26)*
MTX	-	*0.43 (0.21, 0.89)*
ACPA	-	1.54 (0.71, 3.34)

GC glucocorticoid, HR hazard ratio, CI confidence interval, HAQ Health Assessment Questionnaire, CCI Charlson Comorbidity Index, MTX methotrexate, ACPA anti-cyclic citrullinated S

Back to article page